Physician profile
Sharon E Spethman
NPI 1003224650
$2,162.90
in general payments reported to CMS, 2019-2025
18 companies · $412 in 2025
The $412 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $189 · 2022: $453 · 2023: $545 · 2024: $563 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,521.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $753.82 | 2022-2025 | |
| Allergan, INC. | $387.21 | 2021-2022 | |
| Lilly USA, LLC | $192.35 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $135.84 | 2024 | Bimzelx |
| Genzyme Corporation | $100.76 | 2022-2025 | |
| Galderma Laboratories, L.P. | $99.44 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $76.67 | 2023-2024 | Dupixent |
| Leo Pharma INC. | $61.60 | 2024-2025 | Adbry |
| Incyte Corporation | $58.35 | 2023-2024 | Opzelura |
| Bard Peripheral Vascular, INC. | $56.14 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $47.17 | 2023-2024 | Jublia, Arazlo, Duobrii |
| Amgen INC. | $41.53 | 2023-2025 | Enbrel, Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $34.86 | 2023-2024 | Ilumya |
| Janssen Pharmaceuticals, INC | $29.34 | 2021 | |
| Tactile Systems Technology INC | $25.79 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $22.99 | 2023 | Erivedge |
| Siemens Medical Solutions USA, INC. | $22.58 | 2022 | |
| Janssen Biotech, INC. | $16.46 | 2023 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Spethman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.